Understanding hesitancy with revealed preferences across COVID-19 vaccine types

被引:0
|
作者
Kristóf Kutasi
Júlia Koltai
Ágnes Szabó-Morvai
Gergely Röst
Márton Karsai
Péter Biró
Balázs Lengyel
机构
[1] Rice University,Department of Economics
[2] Computational Social Science-Research Center for Educational and Network Studies,Centre for Social Sciences
[3] Eötvös Loránd University,Faculty of Social Sciences
[4] Central European University,Department of Network and Data Science
[5] Eötvös Loránd Research Network,Health and Population Lendület Research Group
[6] Centre for Economic and Regional Studies,Department of Economics
[7] Debrecen University,Bolyai Institute
[8] University of Szeged,Mechanism Design Lendület Research Group
[9] Alfréd Rényi Institute of Mathematics,Department of Operations Research and Actuarial Sciences
[10] Eötvös Loránd Research Network,Agglomeration and Social Networks Lendület Research Group
[11] Centre for Economic and Regional Studies,Corvinus Institute for Advanced Studies
[12] Corvinus University of Budapest,undefined
[13] Eötvös Loránd Research Network,undefined
[14] Centre for Economic and Regional Studies,undefined
[15] Corvinus University of Budapest,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety of vaccines created not only an unprecedented intensity of vaccine related public discourse, but also a historical moment to understand vaccine hesitancy better. Yet, the heterogeneity of hesitancy by vaccine types has been neglected in the existing literature so far. We address this problem by analysing the acceptance and the assessment of five vaccine types. We use information collected with a nationally representative survey at the end of the third wave of the COVID-19 pandemic in Hungary. During the vaccination campaign, individuals could reject the assigned vaccine to wait for a more preferred alternative that enables us to quantify revealed preferences across vaccine types. We find that hesitancy is heterogenous by vaccine types and is driven by individuals’ trusted source of information. Believers of conspiracy theories are more likely to evaluate the mRNA vaccines (Pfizer and Moderna) unacceptable. Those who follow the advice of politicians are more likely to evaluate vector-based (AstraZeneca and Sputnik) or whole-virus vaccines (Sinopharm) acceptable. We argue that the greater selection of available vaccine types and the free choice of the individual are desirable conditions to increase the vaccination rate in societies.
引用
收藏
相关论文
共 50 条
  • [21] Addressing COVID-19 vaccine hesitancy
    Kassianos, George
    Puig-Barbera, Joan
    Dinse, Hannah
    Teufel, Martin
    Tuereci, Oezlem
    Pather, Shanti
    DRUGS IN CONTEXT, 2022, 11
  • [22] Hesitancy Toward a COVID-19 Vaccine
    Linda Thunström
    Madison Ashworth
    David Finnoff
    Stephen C. Newbold
    EcoHealth, 2021, 18 : 44 - 60
  • [23] Trust and COVID-19 vaccine hesitancy
    Carrieri, Vincenzo
    Guthmuller, Sophie
    Wuebker, Ansgar
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [24] Pediatric Vaccine Hesitancy and COVID-19
    Morgans, Heather A.
    Schuster, Jennifer E.
    Warady, Bradley A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (01) : 13 - 14
  • [25] COVID-19 Vaccine Hesitancy and Fertility
    Kocak, Elif Nur
    cetinavci, Dilan
    Yuce, Servet
    INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES, 2022, 10 (02): : 117 - 118
  • [26] Vaccine hesitancy in the COVID-19 era
    Adhikari, Bipin
    Cheah, Phaik Yeong
    LANCET INFECTIOUS DISEASES, 2021, 21 (08): : 1086 - 1086
  • [27] Trust and COVID-19 vaccine hesitancy
    Vincenzo Carrieri
    Sophie Guthmuller
    Ansgar Wübker
    Scientific Reports, 13
  • [28] Misinformation and COVID-19 vaccine hesitancy
    Zimmerman, Tara
    Shiroma, Kristina
    Fleischmann, Kenneth R.
    Xie, Bo
    Jia, Chenyan
    Verma, Nitin
    Lee, Min Kyung
    VACCINE, 2023, 41 (01) : 136 - 144
  • [29] Addressing COVID-19 vaccine hesitancy
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [30] Vaccine hesitancy in the era of COVID-19
    Troiano, G.
    Nardi, A.
    PUBLIC HEALTH, 2021, 194 : 245 - 251